Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.66 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Milestone Pharmaceuticals (MIST) Change in Account Payables (2025 - 2026)

Updated

Milestone Pharmaceuticals (MIST) reported Change in Account Payables of -$1.57 million for Q2 2026, compared with $544,000 a year earlier.

Analysis

Milestone Pharmaceuticals (MIST) Change in Account Payables (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Milestone Pharmaceuticals' Change in Account Payables came in at $3.81 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Milestone Pharmaceuticals 82.17 Mn -88.43 Mn 527,000.00 -1.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.57 Mn
Mar 31, 2026 4.38 Mn
Jun 30, 2025 544,000.00
Mar 31, 2025 452,000.00
API Access

Milestone Pharmaceuticals Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=MIST&period=max&api_key=YOUR_API_KEY